Abstract

Title

Covid-19 pandemic adapted radiotherapy guidelines: are they really followed?

Authors

Elena Galofaro1,2, Claudio Malizia3, Ilario Ammendolia1, Andrea Galuppi1, Alessandra Guido1, Maria Ntreta1, Giambattista Siepe1, Giorgio Tolento1, Antonio Veraldi1, Erica Scirocco1,2, Alessandra Arcelli1,2, Milly Buwenge1,2, Martina Ferioli1,2, Alice Zamagni1,2, Lidia Strigari4, Silvia Cammelli1,2, Alessio Giuseppe Morganti1,2

Authors Affiliations

1Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 2Department of Experimental, Diagnostic, and Specialty Medicine - DIMES, Alma Mater Studiorum Bologna University, Bologna, Italy; 3Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 4Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Purpose or Objective

The emergency situation produced by the COVID-19 pandemic represents a challenge for radiation oncologists (ROs) clinical practice. In our department, we provided guidelines to the ROs regarding omission, delay, or shortening of radiotherapy (RT). The purpose was to reduce patient’s exposure to the hospital environment and to minimize the departmental overcrowding. The aim of this study was to evaluate the ROs compliance to these guidelines.

Materials and Methods

ROs were asked to fill out a data collection form during patients first visits in May and June 2020. Collected data included: ROs age and gender, patient age and residence, RT purpose, treated tumor, dose and fractionation that would have been prescribed outside the pandemic, and RT changes (omitted, delayed, or shortened). The chi-square test and binomial logistic regression were used to analyse the correlation between treatment prescription and collected parameters. 

Results

One hundred twenty-six out of 205 treatments prescribed during the evaluated period were included in this analysis. In fact, 79 treatments were excluded not being considered in the pandemic-adapted guidelines. Treatment was modified in 61.1% of cases. More specifically, treatment was omitted, delayed, or shortened in 7.9%, 15.9%, and 37.3% of patients, respectively. Unmodified treatments were 38.9% (Figure 1). Overall, the reduction of delivered fractions in our department was 27.9%. A statistically significant correlation (p = 0.028) between younger patients age and lower treatment modifications rate was recorded.


Conclusion

Our analysis showed a reasonably high compliance of ROs to pandemic-adapted guidelines. The adopted strategy was effective in reducing the number of admissions to our department.